Pharmacokinetic and efficacy of saquinavir mesylate film coated tablet / ritonavir 1500/100 plus tenofovir/emtricitabine 300/200 mg once daily in HIV pretreated patients

Trial Profile

Pharmacokinetic and efficacy of saquinavir mesylate film coated tablet / ritonavir 1500/100 plus tenofovir/emtricitabine 300/200 mg once daily in HIV pretreated patients

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 06 Apr 2015

At a glance

  • Drugs Saquinavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Jun 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 14 Mar 2008 The expected completion date for this trial is now 1 Nov 2009, according to ClinicalTrials.gov.
    • 14 Mar 2008 Status changed from initiated to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top